US Broker Ratings

Zhengye Biotechnology Holding L (ZYBT): Investor Outlook Amidst Challenging Market Dynamics

Zhengye Biotechnology Holding Limited (ZYBT) is a notable player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic veterinary vaccines. Based in China, the..

Vanda Pharmaceuticals Inc. (VNDA) Stock Analysis: Exploring a 125% Upside Potential Amidst Biotech Innovations

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is capturing the attention of investors with a notable potential upside of 125.95%, according to recent analyst ratings. As a player in the biotechnology sector,..

Pacific Biosciences of California (PACB) Stock Analysis: Exploring a 53% Potential Upside Amid Innovative Genomic Solutions

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a prominent player in the healthcare sector, is making waves in the medical devices industry with its cutting-edge genomic sequencing solutions. The company,..

National Research Corporation (NRC) Stock Analysis: Navigating the Healthcare Analytics Sector with a Compelling 51.24% ROE

National Research Corporation (NRC) is a noteworthy player in the healthcare sector, specializing in health information services. With a market capitalization of approximately $279.37 million, NRC is a prominent provider..

Erasca, Inc. (ERAS) Stock Analysis: Clinical-Stage Innovations with a $3.92 Billion Market Cap and High Analyst Support

Erasca, Inc. (ERAS), a clinical-stage biotechnology company, has been making waves in the healthcare sector with its focus on precision oncology. Headquartered in San Diego, California, Erasca aims to revolutionize..

Chevron Corporation (CVX) Investor Outlook: Navigating a 3.87% Yield Amidst Market Volatility

Chevron Corporation (NYSE: CVX), a stalwart in the energy sector, continues to capture investor attention with its substantial market capitalization of $367.62 billion. As a key player in the Oil..

Senseonics Holdings, Inc. (SENS) Stock Analysis: A 138.85% Potential Upside in the Healthcare Sector

Senseonics Holdings, Inc. (SENS) is making waves in the healthcare sector with its innovative approach to diabetes management. As a commercial-stage medical technology company, Senseonics focuses on the development and..

Aura Biosciences, Inc. (AURA) Stock Analysis: Assessing a Potential 300% Upside in Biotech Innovation

Aura Biosciences, Inc. (NASDAQ: AURA) stands out in the biotechnology sector, attracting significant attention from investors due to its innovative approach to treating solid tumors. A clinical-stage company, Aura is..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a 303% Potential Upside in Gene Therapy Innovation

Abeona Therapeutics Inc. (NASDAQ: ABEO) stands out in the biotechnology sector with its promising advancements in gene and cell therapies, targeting life-threatening diseases. With a focus on precision medicine, the..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Unpacking the 74.59% Potential Upside

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) offers a fascinating opportunity for investors interested in the biotechnology sector, particularly those focused on innovative approaches to genetically defined diseases. With a market capitalization..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Potential 346% Upside with Innovative mRNA Therapies

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) is capturing the attention of investors with its pioneering work in mRNA-based therapies and a staggering potential upside of 346.81%. The San Diego-based biotechnology..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Exploring a 42.86% Potential Upside in the Cell Analysis Solutions Market

Cytek Biosciences, Inc. (NASDAQ: CTKB), a leader in the healthcare sector specializing in medical devices, has garnered notable attention from investors due to its innovative cell analysis solutions. The company,..

Rigel Pharmaceuticals (RIGL) Stock Analysis: Biotech Innovator with a 44% Potential Upside

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a dynamic player in the biotechnology sector, is capturing investor attention with its innovative therapies and substantial growth potential. As a company focused on addressing..

agilon health, inc. (AGL) Investor Outlook: Exploring a 173% Potential Upside Despite Challenges

The healthcare sector is a dynamic arena, often characterized by rapid advancements and persistent challenges. agilon health, inc. (AGL), a company specializing in healthcare services for seniors, finds itself at..

The Pennant Group, Inc. (PNTG) Investor Outlook: Analyzing a 17.3% Potential Upside Amid Robust Revenue Growth

The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector with its impressive growth trajectory and optimistic analyst outlook. As a participant in the Medical Care Facilities..

Wave Life Sciences Ltd. (WVE) Investor Outlook: Analyzing a 163% Potential Upside in Biotechnology

Wave Life Sciences Ltd. (NASDAQ: WVE) is capturing the attention of investors with its compelling potential upside of 163.21%, as outlined by analyst ratings. Operating within the innovative and fast-evolving..

MiMedx Group, Inc (MDXG) Stock Analysis: A Biotech Gem with an 87.5% Potential Upside

MiMedx Group, Inc. (MDXG), a key player in the biotechnology sector, has captured investor attention with its innovative approach to healthcare solutions. Specializing in the development and distribution of placental..

Evolent Health, Inc (EVH) Stock Analysis: Uncovering a Potential 204.66% Upside

Evolent Health, Inc. (NYSE: EVH) stands at a pivotal moment, capturing the attention of investors with the prospect of a remarkable 204.66% upside, according to analyst ratings. Positioned within the..

Mineralys Therapeutics, Inc. (MLYS): An 85.82% Potential Upside Sparks Investor Interest

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is making waves in the healthcare sector, specifically within the biotechnology industry, as it continues its pursuit of innovative treatments for conditions driven by dysregulated..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring a 17% Potential Upside in the Biotech Sector

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a Canadian biopharmaceutical company, continues to capture the attention of investors eager to explore opportunities within the healthcare sector. Specializing in therapies for autoimmune diseases,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds